Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Kirk Look to speak today

<< Previous

Bullboard Posts

Next >>

Comment by CMHarring218431on Sep 11, 2024 3:31pm

298 Views

Post# 36219105

RE:RE:RE:RE:RE:RE:RE:Kirk Look to speak today

I'm Quentin 's buddy??? How the hell did you arrive at that???

That's a reach. Now, because you are so far off in your assessment me, I don't know what to believe when you post. A few months back, you also accused me of being a friend to one of these clowns. Forget the compliments I sent your way....even if you are the former ceo.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?